CTI BioPharma
Why Robinhood?
You can watch CTI BioPharma and buy or sell other stocks, ETFs, and their options commission-free!About CTIC
CTI BioPharma Corp. engages in the development, acquisition, and commercialization of novel targeted therapies for blood-related cancers. It focuses on evaluating pacritinib, its sole product candidate currently in active development, for the treatment of adult patients with myelofibrosis.
CTIC Key Statistics
Stock Snapshot
CTI BioPharma(CTIC) stock is priced at $9.09, giving the company a market capitalization of 1.2B. It carries a P/E multiple of -15.78.
On 2026-04-02, CTI BioPharma(CTIC) stock opened at —, reached a high of —, and a low of —.
CTI BioPharma(CTIC) shares are trading with a volume of 0, against a daily average of 4.57M.
In the last year, CTI BioPharma(CTIC) shares hit a 52-week high of $9.10 and a 52-week low of $4.01.
In the last year, CTI BioPharma(CTIC) shares hit a 52-week high of $9.10 and a 52-week low of $4.01.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.